Canada Pension Plan Investment Board Has $389,000 Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Canada Pension Plan Investment Board cut its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 73.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 20,500 shares of the medical instruments supplier's stock after selling 57,800 shares during the period. Canada Pension Plan Investment Board's holdings in DENTSPLY SIRONA were worth $389,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Pacer Advisors Inc. grew its stake in DENTSPLY SIRONA by 15,105.1% in the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock valued at $85,478,000 after buying an additional 4,473,972 shares during the last quarter. Nuance Investments LLC grew its stake in DENTSPLY SIRONA by 25.0% in the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock valued at $257,103,000 after buying an additional 2,708,097 shares during the last quarter. Norges Bank acquired a new position in DENTSPLY SIRONA in the 4th quarter valued at about $45,730,000. Cooke & Bieler LP grew its stake in DENTSPLY SIRONA by 24.3% in the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock valued at $174,101,000 after buying an additional 1,794,391 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its stake in DENTSPLY SIRONA by 206.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock valued at $49,990,000 after buying an additional 1,244,326 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have issued reports on XRAY shares. Mizuho cut their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. Wells Fargo & Company cut their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a report on Friday, February 28th. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a report on Friday, February 28th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Finally, Morgan Stanley downgraded shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a report on Tuesday, April 15th. Thirteen investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $22.58.

DENTSPLY SIRONA Trading Up 0.9 %

XRAY traded up $0.12 during trading on Monday, reaching $13.87. 2,260,426 shares of the stock traded hands, compared to its average volume of 2,970,223. The stock has a market capitalization of $2.76 billion, a PE ratio of -6.70, a P/E/G ratio of 1.80 and a beta of 0.92. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The stock's 50-day moving average is $14.99 and its 200 day moving average is $18.17. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $31.00.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.61%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio is -14.07%.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now directly owns 81,971 shares of the company's stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.52% of the stock is owned by company insiders.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.